These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19357068)

  • 1. Diabetes Ten City Challenge: final economic and clinical results.
    Fera T; Bluml BM; Ellis WM
    J Am Pharm Assoc (2003); 2009; 49(3):383-91. PubMed ID: 19357068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program.
    Fera T; Bluml BM; Ellis WM; Schaller CW; Garrett DG
    J Am Pharm Assoc (2003); 2008; 48(2):181-190. PubMed ID: 18359731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes.
    Garrett DG; Bluml BM
    J Am Pharm Assoc (2003); 2005; 45(2):130-7. PubMed ID: 15868754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.
    Cranor CW; Bunting BA; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):173-84. PubMed ID: 12688435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program.
    Cranor CW; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):149-59. PubMed ID: 12688433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Virtual Pharmacy Review Program: A Population Health Case Study.
    Muraywid B; Butkievich LE; Myers B
    J Manag Care Spec Pharm; 2020 Jan; 26(1):24-29. PubMed ID: 31880223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving outcomes for diverse populations disproportionately affected by diabetes: final results of Project IMPACT: Diabetes.
    Bluml BM; Watson LL; Skelton JB; Manolakis PG; Brock KA
    J Am Pharm Assoc (2003); 2014; 54(5):477-85. PubMed ID: 25216877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacist-provided extended diabetes care.
    Doucette WR; Witry MJ; Farris KB; McDonough RP
    Ann Pharmacother; 2009 May; 43(5):882-9. PubMed ID: 19401477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program.
    Cranor CW; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):160-72. PubMed ID: 12688434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study.
    Kraemer DF; Kradjan WA; Bianco TM; Low JA
    J Pharm Pract; 2012 Apr; 25(2):169-79. PubMed ID: 21987530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the economic and clinical impact of community pharmacist-driven pharmacy benefit management services.
    Jackson DL; Michaels NM; Melson B; Bruder E; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S91-S94. PubMed ID: 31203015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling.
    Rodriguez de Bittner M; Chirikov VV; Breunig IM; Zaghab RW; Shaya FT
    J Am Pharm Assoc (2003); 2017; 57(1):102-108.e4. PubMed ID: 27769877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.
    Bunting BA; Smith BH; Sutherland SE
    J Am Pharm Assoc (2003); 2008; 48(1):23-31. PubMed ID: 18192127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service.
    McCord AD
    Pharmacotherapy; 2006 Feb; 26(2):248-53. PubMed ID: 16466329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomic analysis of the diabetes initiative program: a pharmacist-physician collaborative care model.
    Franklin BE; Farland MZ; Thomas J; McFarland MS; Ray SM; Byrd DC
    Ann Pharmacother; 2013 Dec; 47(12):1627-34. PubMed ID: 24259610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.
    McAdam-Marx C; Dahal A; Jennings B; Singhal M; Gunning K
    J Manag Care Spec Pharm; 2015 Jun; 21(6):452-68. PubMed ID: 26011547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of clinical pharmacist positions through sustainable funding.
    Moore GD; Kosirog ER; Vande Griend JP; Freund JE; Saseen JJ
    Am J Health Syst Pharm; 2018 Jul; 75(13):978-981. PubMed ID: 29941536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of community pharmacist-led health coaching on clinical outcomes.
    Watkins VA; Michaels NM; Jackson DL; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2020; 60(3S):S65-S69. PubMed ID: 32439280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing a pharmacist-led in-home medication coaching service via community-based partnerships.
    Akers JL; Meer G; Kintner J; Shields A; Dillon-Sumner L; Bacci JL
    J Am Pharm Assoc (2003); 2019; 59(2):243-251. PubMed ID: 30638730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.